European application, no grantEurope
Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system
EP 1047779 A2 · Applicant: BLOOD CENTER RESEARCH FOUNDATION
Overview
The published document from the EPO: abstract, claims, description and drawings. Open it full size
Read the whole patent
Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 19, 1999 and never granted as a European patent. Had it been granted, its 20-year term would have ended January 19, 2019.
- A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by July 19, 2024.
- We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledJanuary 19, 1999
PublishedNovember 2, 2000
GrantedNever granted
Term endedJanuary 19, 2019
Application numberEP 99903179
Classification (CPC)C07K14/47
Timeline
Timeline From EPO dates
Sources & verification
Official EPO records
Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.